Vasomedical Announces Application for Listing on the OTC Bulletin Board ("OTCBB")

Vasomedical Announces Application for Listing on the OTC Bulletin Board ("OTCBB")

Investor Relations:

[email protected]

Vasomedical, Inc. (“Vasomedical”) (OTCQB: VASO), a diversified medical technology company specializing in the design, manufacture and sale of medical devices and in the domestic sale of diagnostic imaging products, today announced its engagement of a full service broker dealer to sponsor Vasomedical’s stock for quotation on the OTC Bulletin Board (“OTCBB”). The OTCBB is an electronic quotation system that displays real-time quotes, last-sales price, and volume information for many over-the-counter (“OTC”) securities that are not listed on the Nasdaq Stock Market or a national securities exchange.

Currently, the Company’s stock is quoted on OTC Link (previously, “Pink Sheets”) operated by OTC Markets Group, Inc. By listing onto the OTCBB, the company believes that its shareholders may potentially benefit by, among other things, additional exposure to the investment community, increased liquidity, and enhanced corporate image. The application is subject to acceptance by the Financial Industry Regulatory Authority (“FINRA”).

Vasomedical, Inc. is a diversified medical technology company specializing in the manufacture and sale of medical devices and in the domestic sale of diagnostic imaging products. The Company operates through three wholly owned subsidiaries. Vasomedical Solutions manages and coordinates the design, manufacture and sales of EECP Therapy systems, its core product, as well as other medical equipment operations; Vasomedical Global operates the Company’s China-based subsidiaries; and Vaso Diagnostics, d/b/a VasoHealthcare, is the operating subsidiary for the sales representation of GE Healthcare diagnostic imaging products. Additional information is available on the Company's website at .